Cargando…

Correction: p53 and metabolism: from mechanism to therapeutics

Detalles Bibliográficos
Autores principales:	Simabuco, Fernando M., Morale, Mirian G., Pavan, Isadora C.B., Morelli, Ana P., Silva, Fernando R., Tamura, Rodrigo E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188054/ https://www.ncbi.nlm.nih.gov/pubmed/30338044 http://dx.doi.org/10.18632/oncotarget.26181

Ejemplares similares

p53 and metabolism: from mechanism to therapeutics
por: Simabuco, Fernando M., et al.
Publicado: (2018)

Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses
por: Simabuco, Fernando Moreira, et al.
Publicado: (2020)

GADD45α and γ interaction with CDK11p58 regulates SPDEF protein stability and SPDEF-mediated effects on cancer cell migration
por: Tamura, Rodrigo E., et al.
Publicado: (2016)

Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
por: Morale, Mirian Galliote, et al.
Publicado: (2022)

Correction: Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53
por: Page, Angustias, et al.
Publicado: (2017)

S6Ks isoforms contribute to viability, migration, docetaxel resistance and tumor formation of prostate cancer cells
por: Amaral, Camila L., et al.
Publicado: (2016)

Correction: Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
por: Tal, Perry, et al.
Publicado: (2019)

Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers
por: Ge, Yuanlong, et al.
Publicado: (2019)

Correction: Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2
por: Wiech, Milena, et al.
Publicado: (2013)

Characterization of the different S6Ks isoforms interacting partners
por: Pavan, Isadora, et al.
Publicado: (2014)

The Hallmarks of Flavonoids in Cancer
por: Ponte, Luis Gustavo Saboia, et al.
Publicado: (2021)

Metformin impairs cisplatin resistance effects in A549 lung cancer cells through mTOR signaling and other metabolic pathways
por: Morelli, Ana Paula, et al.
Publicado: (2021)

Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Woodfield, Sarah E., et al.
Publicado: (2021)

Correction: The p53 isoform delta133p53ß regulates cancer cell apoptosis in a RhoB-dependent manner
por: Arsic, Nikola, et al.
Publicado: (2017)

Checking NEKs: Overcoming a Bottleneck in Human Diseases
por: Peres de Oliveira, Andressa, et al.
Publicado: (2020)

Correction: Regulation of p53 Level by UBE4B in Breast Cancer
Publicado: (2014)

Correction: Regulation of p53 Level by UBE4B in Breast Cancer
Publicado: (2015)

Correction: Mechanical Stretch Inhibits MicroRNA499 via p53 to Regulate Calcineurin-A Expression in Rat Cardiomyocytes
por: Chual, Su-Kiat, et al.
Publicado: (2016)

Correction: Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
por: Jordan, Jennifer J., et al.
Publicado: (2008)

Correction: Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
por: Jordan, Jennifer J., et al.
Publicado: (2008)

Correction: Leptin Is an Anti-Apoptotic Effector in Placental Cells Involving p53 Downregulation
Publicado: (2014)

Correction: Phosphorylation of Daxx by ATM Contributes to DNA Damage-Induced p53 Activation
por: Tang, Jun, et al.
Publicado: (2013)

Correction: APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
por: Zhang, Qiang, et al.
Publicado: (2019)

Correction to: M1 macrophage dependent-p53 regulates the intracellular survival of mycobacteria
por: Lim, Yun-Ji, et al.
Publicado: (2019)

TLR4 and SARM1 modulate survival and chemoresistance in an HPV-positive cervical cancer cell line
por: Morale, Mirian Galliote, et al.
Publicado: (2022)

Correction: Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway
por: Wang, Guihua, et al.
Publicado: (2021)

Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
por: Agarwal, Saurabh, et al.
Publicado: (2018)

Correction: Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo
por: El Khatib, Mona, et al.
Publicado: (2018)

Correction to: Regulation of GAD65 expression by SMAR1 and p53 upon Streptozotocin treatment
por: Singh, Sandeep, et al.
Publicado: (2020)

Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
por: Ladds, Marcus J. G. W., et al.
Publicado: (2018)

Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
por: Ladds, Marcus J. G. W., et al.
Publicado: (2023)

Correction To: Signaling pathways in obesity: mechanisms and therapeutic interventions
por: Wen, Xue, et al.
Publicado: (2022)

Correction: The Pharmacodynamics of the p53-Mdm2 Targeting Drug Nutlin: The Role of Gene-Switching Noise
Publicado: (2015)

Correction: Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis
por: Wang, Zhun, et al.
Publicado: (2018)

Correction to: The TRIM protein Mitsugumin 53 enhances survival and therapeutic efficacy of stem cells in murine traumatic brain injury
por: Guan, Fangxia, et al.
Publicado: (2021)

Correction: CSF1 Is a Novel p53 Target Gene Whose Protein Product Functions in a Feed-Forward Manner to Suppress Apoptosis and Enhance p53-Mediated Growth Arrest
por: Azzam, Gregory, et al.
Publicado: (2013)

Correction: Hypersensitivity of Primordial Germ Cells to Compromised Replication-Associated DNA Repair Involves ATM-p53-p21 Signaling
Publicado: (2014)

Correction: Wild Type p53 Transcriptionally Represses the SALL2 Transcription Factor under Genotoxic Stress
Publicado: (2014)

Correction: Global Conformational Selection and Local Induced Fit for the Recognition between Intrinsic Disordered p53 and CBP
por: Yu, Qingfen, et al.
Publicado: (2013)

Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma
por: Costa, Caterina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kmr7d19vn1oa0o0916rkd5clv8